UICC and IFPMA editorial in Re:solve Public Health: “A collective approach can improve access to cancer care.”

Closing the widening access gap to cancer care requires willing collaboration and a collective effort by organisations from across sectors pulling together towards a common ambition.

In a joint article for Re:solve Public Health, Melissa Rendler-Garcia, Senior Adviser and ATOM Coalition Project Lead at UICC, and Vanessa Peberdy, deputy director for Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), highlight the alarming escalation of cancer cases worldwide, and explain the need for a global, collective response and how the ATOM Coalition, a new partnership established by UICC and its partners, is helping to transform access to life-saving cancer medicine in low- and lower middle-income countries.

Read the article on the ATOM Coalition

Tags ATOM Coalition Access

Last update

Thursday 30 July 2026

Related content

Woman speaking at an ATOM Coalition symposium

The UICC-led ATOM Coalition recently convened representatives from El Salvador and Honduras to discuss how to improve access to diagnostics, medicines, and patient support services for chronic myeloid leukemia (CML). 

Close up of a hand of a hospital patient receiving IV antibiotics

Andrew Whitehead of UICC partner Bristol Myers Squibb writes about how equitable access to innovative cancer treatments cannot rest on a single intervention, but rather depends on stronger health systems spanning financing, diagnostics, workforce capacity and patient engagement.